Isolated Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Hypertrophic Pachymeningitis

Jeffrey Maneval1, Bronwyn Bryant2, Adam Ulano3

  • 1From the Departments of Neurology.

Insights

This study details a rare case of vasculitic hypertrophic pachymeningitis associated with myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA). Prompt immunomodulatory treatment led to significant clinical and imaging improvements.

Area of Science:

  • Neurology
  • Immunology
  • Rheumatology

Background:

  • Hypertrophic pachymeningitis is a rare condition characterized by thickening of the dura mater.
  • Vasculitis, particularly antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, can affect the central nervous system.
  • Myeloperoxidase-ANCA (MPO-ANCA) is a specific serological marker associated with certain types of vasculitis.

Observation:

  • A 65-year-old man presented with progressive headaches, gait instability, and weight loss.
  • Diagnostic workup revealed positive perinuclear ANCA (p-ANCA) with myeloperoxidase specificity, and lymphocytic pleocytosis in cerebrospinal fluid.

Findings:

  • Neuroimaging demonstrated isolated hypertrophic pachymeningitis.
  • The patient experienced clinicoradiographic resolution following immunomodulatory pharmacotherapy.

Implications:

  • This case highlights the importance of considering ANCA-associated vasculitis in the differential diagnosis of hypertrophic pachymeningitis.
  • Early diagnosis and treatment with immunomodulatory agents are crucial for favorable outcomes in this rare condition.

Related Concept Videos